Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of Water disinfection model (Sodium bromate) M970060

 

CASRN: 7789-38-0

Formula: Br-H-O3.Na

Synonyms/Common Names

  • Bromic acid, sodium salt
  • Sodium bromate (Water disinfection mode)

Short-Term Toxicity

  • 2 weeks (Topical Application)  (C97013B)  Completed 
    • Mice: FVB/N
    • Dose: 0, 16, 32, 64, 128, OR 256 MG/KG.
  • 27 weeks (Dosed-Water)  (C97013A)  Completed 
    • GMM-06 (NIH Number: 07-4423)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Sodium Bromate (CASRN 7789-38-0) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal and Drinking Water Studies) and Carcinogenicity Studies of Sodium Bromate in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water Studies)
    • Mice: P53 +/- (C57BL/6)
    • Dose: 0, 80, 400, OR 800 MG/L.
  • 43 weeks (Dosed-Water)  (C97013A)  Completed 
    • GMM-06 (NIH Number: 07-4423)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Sodium Bromate (CASRN 7789-38-0) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal and Drinking Water Studies) and Carcinogenicity Studies of Sodium Bromate in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water Studies)
    • Mice: P53 +/- (C57BL/6)
    • Dose: 0, 80, 400, OR 800 MG/L.
  • 26 weeks (Topical Application)  (C97013B)  Completed 
    • GMM-06 (NIH Number: 07-4423)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Sodium Bromate (CASRN 7789-38-0) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal and Drinking Water Studies) and Carcinogenicity Studies of Sodium Bromate in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water Studies)
    • Mice: Tg.AC (FVB/N) Hemizygous
    • Dose: 0, 128, OR 256 MG/KG.
  • 39 weeks (Topical Application)  (C97013B)  Completed 
    • GMM-06 (NIH Number: 07-4423)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Sodium Bromate (CASRN 7789-38-0) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal and Drinking Water Studies) and Carcinogenicity Studies of Sodium Bromate in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water Studies)
    • Mice: Tg.AC (FVB/N) Hemizygous
    • Dose: 0, 128, OR 256 MG/KG.
  • 27 weeks (Dosed-Water)  (C97013H)  Completed 
    • GMM-06 (NIH Number: 07-4423)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Sodium Bromate (CASRN 7789-38-0) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal and Drinking Water Studies) and Carcinogenicity Studies of Sodium Bromate in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water Studies)
    • Mice: Tg.AC (FVB/N) Hemizygous
    • Dose: 0, 80, 400, OR 800 MG/L.
  • 43 weeks (Dosed-Water)  (C97013H)  Completed 
    • GMM-06 (NIH Number: 07-4423)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Sodium Bromate (CASRN 7789-38-0) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal and Drinking Water Studies) and Carcinogenicity Studies of Sodium Bromate in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water Studies)
    • Mice: Tg.AC (FVB/N) Hemizygous
    • Dose: 0, 80, 400, OR 800 MG/L.